🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tbsp Serving Size
33 Servings
Amino acid/Protein Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Calories
25 {Calories}
Total Fat
Cholesterol
Sodium
40 mg (1.6% DV)
Total Carbohydrates
5 g (2% DV)
Net Carbohydrates
Protein
6 g
Active Ingredients

Other Ingredients

a proprietary pH-Xact liquid-based delivery system

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (98% of products) Structure/Function (78% of products) Nutrient (56% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

SUGGESTED USE: As a dietary supplement, take 1 TBSP 3 times daily preferably between meals. Shake well. No refrigeration needed, but may enhance flavor.

⚠️ Warnings & Precautions

Warnings: Do not use if you are pregnant or nursing. Not intended for any persons under the age of 18. Seek the advice of your healthcare professional if you have any medical condition or are taking any medications. Discontinue use if you are experiencing any side-effects.

Additional Information

Keep lid tightly closed in a cool, dry place away from children.

*For maximum potency & bio-availability

CHOCOLATE SYRUP

FLEX WHEELER SIGNATURE EDITION

GROWTH/RECOVERY

In God We Trust EU Plant #1000135313

pH-Xact Delivery Technology It's not how much you take, it's how much you absorb.

U.S. and International Patents Pending

Your daily values may be higher or lower depending on your calorie needs.

CO# AAL140B-16

Product Details

UPC / SKU 7 37190 00146 2
DSLD Entry Date 2011-10-26
Product Type Amino acid/Protein
Form Liquid
DSLD ID 626
Data Updated 2026-04-11

Research Evidence

50 Research Sources
47 Avg Quality Score
28 Rct
13 Clinical Trial
5 Guideline
4 Systematic Review
A Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors.
Guideline International journal of molecular sciences 2025
B Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors.
Guideline Internal medicine journal 2025
B Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates
Systematic Review The Cochrane database of systematic reviews 2020
B [Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)].
Guideline Zhonghua zhong liu za zhi [Chinese journal of oncology] 2025
B [Chinese expert consensus on epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer (2025 edition)].
Guideline Zhonghua yi xue za zhi 2025
B Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency.
Guideline Journal of inherited metabolic disease 2025
B Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating
Rct Cognitive, affective & behavioral neuroscience 2020
B Effect of Amino Acid Supplementation on Iron Regulation after Endurance Exercise
Rct Nutrients 2023
C Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta-analysis with Meta-regression
Systematic Review Sports medicine - open 2024
C The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic Review
Systematic Review Plant foods for human nutrition (Dordrecht, Netherlands) 2020
View all evidence for Tyrosine →

Compare Similar Products

View all Tyrosine products →